Mnemo Therapeutics
Seedtable Score
60
Startups
1
Funding Rounds
1
Investors
$89.62m
Money raised
Overview
Mnemo Therapeutics, based in Paris, presents significant potential as a biotechnology firm focused on life sciences advancements. Their B2B model positions them well for collaborations within the healthcare industry. Backed by Sofinnova Partners, Mnemo has strong financial support. Their emphasis on advancing biotechnology offers a competitive edge, although reliance on existing medical technologies might slow innovation. However, their specialized focus allows them to target niche markets within the biotech sector, potentially leading to substantial growth opportunities despite the innovation challenges.
- Website: https://mnemo-tx.com
- Business model: b2b
- Company size: 101 - 251 employees
- Headquarters: Paris, France
- Founded: 2019
- Social accounts: Twitter Linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Investors (1)
Sofinnova Partners
Healthcare, Manufacturing, Health Tech, Synthetic biology, Technology, ...
DetailsFunding
Funding series
Funding Series Analysis
The company Mnemo Therapeutics has raised a total of $89.62m in funding over 1 rounds.
Key Insights:
- Series A: $89.62m
Mnemo Therapeutics Series A (2021, $89M)
$89.62m